Home Telemonitoring in Patients at High Risk for Readmission

Status Completed

Clinical Trial Summary

This study will evaluate the efficacy of home telemonitoring as an intervention to decrease hospital readmissions in patients at high risk for readmission. The overall readmission rate for high-risk MCF hospital patients is approximately 20%. Currently a system is in place to identify and score all MCF patients for their risk of readmission. This score is based on multiple variables including but not limited to: co-morbid conditions, patient's health literacy, whether they are a Medicare/Medicaid patient, their in-home social support, and whether they have had prior hospital admissions within the previous year. The literature shows that home telemonitoring of patients has had mixed results for effectiveness at preventing hospitalizations and emergency department visits. Many of these reports have restricted studies to patients with specific diseases or general characteristics; some have shown improved results while others have not. No study has examined patients who are high risk for readmission to determine if home telemonitoring for 30 days post-discharge reduces the risk for 30-day readmission.

Clinical Trial Description

We hope to enroll a total of 1900 participants, 950 in each arm, over the next 2 years. One arm will be the telemonitoring group and one arm will be the standard of care group. Participants will be in the study for 30 days. Participants in the telemonitoring group will receive a Telestation, blood pressure monitor, and pulse oximeter. If the participant also has congestive heart failure, they will receive a scale. All of these vital measurements are to be taken on a daily basis along with survey questions on how the patient feels. If set parameters are out of the normal range, a flag will trigger that requires follow up/intervention from a nurse by telephone. In some cases, the participant might need to come back in to see a physician through the outpatient clinic. The participant in the standard of care group will be contacted via phone 30 days after discharge to learn if they were readmitted to any hospitals or had any emergency room visits during the past 30 days. This data will be collected via Philips software and also entered into the RedCap database here at Mayo Clinic. ;

Study Design

Related Conditions & MeSH terms

Inpatients

Clinical Trial Details

NCT number	NCT02136186
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	October 2014
Completion date	July 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01931553` - A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine	N/A
Recruiting	`NCT06086184` - Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder	N/A
Recruiting	`NCT05359367` - A Novel Approach to Enhance True Recovery After Stroke
Enrolling by invitation	`NCT01397682` - Epidemiological Observatory on the Health Conditions of Inpatients Aged 65 or Older at the INRCA Research Hospitals
Not yet recruiting	`NCT06424808` - Pilot Study for the Validity of a Content-based Information Provision Tool Aimed at Improving the Hospitalization Experience of Liver Transplant Patients	N/A
Active, not recruiting	`NCT04283994` - Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)	N/A
Completed	`NCT04114110` - RTLS Technology Study
Completed	`NCT03829813` - Effects of Music Therapy on Mood, Pain, Patient and Staff Satisfaction on Adult Inpatient Neurological Units	N/A
Completed	`NCT03712332` - Inpatient Distress Tolerance Group Intervention Pilot	N/A
Withdrawn	`NCT03323190` - An Educational Intervention to Improve Disease Management Knowledge of Hospitalized Patients With COPD	N/A
Completed	`NCT04013997` - Exoskeleton-assisted Walking in SCI Inpatient Rehabilitation	N/A
Recruiting	`NCT05886686` - Contactless Vital Signs Measurement Study (CVMS)
Completed	`NCT04281784` - Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.